Immediate Impact
71 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Works of Andrey Rymar being referenced
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling
2020
Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF -mutant lung cancer
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Andrey Rymar | 71 | 8 | 3 | 34 | 29 | 3 | 86 | |
| Stephanie L. Stout | 40 | 18 | 3 | 21 | 11 | 5 | 92 | |
| Adelyn Wise | 84 | 6 | 3 | 68 | 8 | 5 | 106 | |
| О. В. Головенко | 84 | 12 | 7 | 39 | 16 | 4 | 164 | |
| Haoxuan Tong | 113 | 2 | 5 | 33 | 17 | 2 | 135 | |
| Sara Marlow | 123 | 5 | 15 | 32 | 19 | 2 | 134 | |
| Ben Jenkins | 128 | 4 | 7 | 52 | 19 | 6 | 168 | |
| Daniel Winokur | 166 | 9 | 5 | 89 | 20 | 4 | 191 | |
| Nikhil Shirahatti | 96 | 17 | 5 | 62 | 12 | 5 | 171 | |
| Nadine Reischmann | 69 | 5 | 2 | 30 | 9 | 5 | 91 | |
| Jorge Vaz Pinto Neto | 103 | 5 | 26 | 49 | 27 | 6 | 172 |
All Works
Loading papers...